Kerry completes acquisition of science-backed branded botanical extract company Natreon

Kerry, one of the world’s leading taste and nutrition companies, has announced it has completed the acquisition of U.S.-based Natreon, Inc., a leading supplier of branded Ayurvedic botanical ingredients.

Natreon supplies branded and scientifically studied and tested Ayurvedic extracts to the dietary supplement and functional food and beverage industries across the globe. The acquisition significantly expands Kerry’s leadership position and ProActive Health portfolio of science-backed branded ingredients, furthering the company’s technology growth. The branded ingredients in Natreon’s portfolio are protected by a wide range of U.S. and foreign patents and supported by a total of 52 clinical studies which support the efficacy of their health benefits. Natreon’s portfolio consists of the following:

• Sensoril^® – Ashwagandha extract for cognitive health benefits including stress, anxiety, and sleep.
• PrimaVie^® – Shilajit extract for sports nutrition and healthy aging.
• Capros^® – Amla extract for cardiovascular support.
• Crominex^® – Chromium complex for diabetes.
• Ayuflex^® – Terminalia chebula extract for bone and joint health benefits.
• Ayuric^® – Terminalia bellirica extract for uric acid health.

The ingredients will be integrated into Kerry’s ProActive Health portfolio and leveraged by Kerry’s broad customer base. The ingredients will be supported by Kerry’s global application and R&D network, including continued investment in the science and clinical evidence supporting the brands.

Kerry has been building a leading position in science-backed functional ingredients within its ProActive Health portfolio for the past several years, most recently with the acquisition of Spain-based company Biosearch Life in 2021.